SAFECODE DRUG TECHNOLOGIES CORP. — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$0

Net Income/Loss (FY2012)

-$2.1M

Total Assets (FY2012)

$174.3K

Total Equity (FY2012)

$112.7K

Cash Flows from Operating Activities (FY2012)

-$98.1K

Source: SAFECODE DRUG TECHNOLOGIES CORP. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.